Press Release : Shelter Pharma Limited Launch of D3 Cure Capsules
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Ltd, an Ahmedabad-based herbal and wellness company founded in 1965, announced the launch of D3 Cure Capsules under its Nutraceutical portfolio on December 15, 2025. The product is a Vitamin D3 supplement aimed at preventing and treating Vitamin D deficiency, supporting bone health, immunity, muscle function, and overall wellness. The company stated this launch is part of a broader strategy to grow its Nutraceutical segment and strengthen its presence in preventive healthcare, including in international markets. No specific revenue targets, order values, or financial guidance were disclosed in the press release.
This is a routine product line expansion announcement rather than a major deal or earnings event, so the near-term impact on the stock or shareholder value is likely limited. It signals the company's intent to diversify into the fast-growing nutraceutical segment, which could support long-term growth if the product gains traction, but investors should wait for actual sales data.